Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice.

Liu W, Li H, Hong SH, Piszczek GP, Chen W, Rodgers GP.

Oncogene. 2016 Oct 6;35(40):5237-5247. doi: 10.1038/onc.2016.58. Epub 2016 Mar 14.

2.

Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.

Suknuntha K, Ishii Y, Tao L, Hu K, McIntosh BE, Yang D, Swanson S, Stewart R, Wang JY, Thomson J, Slukvin I.

Stem Cell Res. 2015 Nov;15(3):678-93. doi: 10.1016/j.scr.2015.10.015. Epub 2015 Oct 31.

3.

Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer.

Clemmensen SN, Glenthøj AJ, Heebøll S, Nielsen HJ, Koch C, Borregaard N.

J Cell Mol Med. 2015 Dec;19(12):2865-73. doi: 10.1111/jcmm.12679. Epub 2015 Sep 28.

4.
5.

Olfactomedin proteins: central players in development and disease.

Anholt RR.

Front Cell Dev Biol. 2014 Feb 26;2:6. doi: 10.3389/fcell.2014.00006. eCollection 2014 Feb 26. Review.

6.

Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.

Zhu J, Chin K, Aerbajinai W, Kumkhaek C, Li H, Rodgers GP.

Blood. 2014 Aug 14;124(7):1146-56. doi: 10.1182/blood-2013-10-534842. Epub 2014 Jun 9.

7.

Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.

Kagedan D, Lecker I, Batruch I, Smith C, Kaploun I, Lo K, Grober E, Diamandis EP, Jarvi KA.

Clin Proteomics. 2012 Feb 6;9(1):2. doi: 10.1186/1559-0275-9-2.

8.

Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.

VanDussen KL, Carulli AJ, Keeley TM, Patel SR, Puthoff BJ, Magness ST, Tran IT, Maillard I, Siebel C, Kolterud Å, Grosse AS, Gumucio DL, Ernst SA, Tsai YH, Dempsey PJ, Samuelson LC.

Development. 2012 Feb;139(3):488-97. doi: 10.1242/dev.070763. Epub 2011 Dec 21.

9.

Olfactomedin 4 defines a subset of human neutrophils.

Clemmensen SN, Bohr CT, Rørvig S, Glenthøj A, Mora-Jensen H, Cramer EP, Jacobsen LC, Larsen MT, Cowland JB, Tanassi JT, Heegaard NH, Wren JD, Silahtaroglu AN, Borregaard N.

J Leukoc Biol. 2012 Mar;91(3):495-500. doi: 10.1189/jlb.0811417. Epub 2011 Dec 20.

10.

Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice.

Vlantis K, Wullaert A, Sasaki Y, Schmidt-Supprian M, Rajewsky K, Roskams T, Pasparakis M.

J Clin Invest. 2011 Jul;121(7):2781-93. doi: 10.1172/JCI45349. Epub 2011 Jun 23.

11.

Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.

Dassen H, Punyadeera C, Delvoux B, Schulkens I, Marchetti C, Kamps R, Klomp J, Dijcks F, de Goeij A, D'Hooghe T, Kyama C, Ederveen A, Dunselman G, Groothuis P, Romano A.

Am J Pathol. 2010 Nov;177(5):2495-508. doi: 10.2353/ajpath.2010.100026.

12.

Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Liu W, Lee HW, Liu Y, Wang R, Rodgers GP.

Blood. 2010 Dec 2;116(23):4938-47. doi: 10.1182/blood-2009-10-246439. Epub 2010 Aug 19.

13.

Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.

Liu W, Yan M, Liu Y, Wang R, Li C, Deng C, Singh A, Coleman WG Jr, Rodgers GP.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11056-61. doi: 10.1073/pnas.1001269107. Epub 2010 Jun 1.

14.

Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology.

Tomarev SI, Nakaya N.

Mol Neurobiol. 2009 Oct;40(2):122-38. doi: 10.1007/s12035-009-8076-x. Epub 2009 Jun 26. Review.

Supplemental Content

Support Center